Compounding engineered mesenchymal stem cell-derived exosomes: A potential rescue strategy for retinal degeneration

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Nanotechnology

Background:

• Retinal degenerative diseases are increasing globally, driven by aging populations.
• These conditions cause progressive photoreceptor cell damage with limited treatment options.
• Mesenchymal stem cell-derived exosomes (MSC-EXOs) are a promising non-cellular nanotherapeutic approach.

Purpose of the Study:

• To review advances in using microRNAs (miRNAs) within MSC-EXOs for retinal degeneration treatment.
• To discuss strategies for engineering therapeutic MSC-EXOs.
• To introduce the novel concept of Compound Engineered MSC-EXOs (Co-E-MSC-EXOs) for enhanced therapy.

Main Methods:

• Review of recent scientific literature on MSC-EXOs and miRNAs in retinal degeneration.
• Discussion of engineering strategies to enhance MSC-EXO drug-loading, targeting, and stability.
• Exploration of the potential of Co-E-MSC-EXOs for multifaceted therapeutic effects.

Main Results:

• Engineered MSC-EXOs demonstrate improved characteristics for therapeutic applications.
• miRNAs within MSC-EXOs play a crucial role in mediating therapeutic effects.
• Co-E-MSC-EXOs offer a novel strategy to overcome limitations of single-function engineered exosomes.

Conclusions:

• Engineered MSC-EXOs, particularly Co-E-MSC-EXOs, represent a significant advancement in nanotherapeutics for retinal degeneration.
• Further research into Co-E-MSC-EXOs is warranted to address clinical application challenges.
• This approach holds potential for improved treatment of age-related macular degeneration and retinitis pigmentosa.